Combined treatment with 2′-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model-Reference-Cited by-同舟云学术

Combined treatment with 2′-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model

Published:1992-09 Issue:3 Volume:19 Page:193-206
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Feng J.S.,Crouch J.Y.,Tolman R.L.,Lucia H.L.,Hsiung G.D.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference10 articles.

1. A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate;Biron,1986

2. Dose-effect analysis with microcomputers: Quantitation of ED50, LD50, synergism, antagonism, low dose risk, receptor-ligand binding and enzyme kinetic;Chou,1987

3. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine against cytomegalovirus infection in a guinea pig model;Fong;Antiviral Res.,1987

4. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type-2 in vitro and in vivo;Freitas;Antiviral Res.,1989

5. Comparison of the modes of antiviral action of 2′-nor-deoxyguanosine and its cyclic phosphate, 2′-nor-cyclic GMP;Germershausen;Antimicrob. Agents Chemother,1986

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs;Antiviral Research;2005-01

2. Prophylactic treatment of cytomegalovirus infection with traditional herbs;Antiviral Research;1996-10

3. Mysteries and miracles;Clinical and Diagnostic Virology;1995-04